80195-36-4

Cefdaloxime is an orally administered cephalosporin that has activity against Haemophilus influenzae, a bacteria that causes meningitis in humans. Cefdaloxime is also the active metabolite of HR916K, a cephalosporin ester.

ChEBI: Cefdaloxime is a cephalosporin compound having methoxymethyl and [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino side-groups; a third-generation cephalosporin antibiotic. It has a role as an antibacterial drug.